A Beltsis, A Ilias - Annals of Gastroenterology, 2009 - libnet.gr Chronic Hepatitis C is a major public health issue, affecting >2% of the worlds population.
Combination treatment with pegylated interferon alfa and ribavirin is successful in achiev- ing
long-term viral suppression in ... Related articles - View as HTML - All 3 versions
C Cammà, G Cabibbo, F Bronte, M Enea, A Licata, M … - Journal of Hepatology, 2009 - Elsevier MEDLINE as well as a manual search were used. Studies were included if they were controlled or
uncontrolled trials, if they had been published as full-length papers and if they included
non-responders to standard or ... Related articles - All 24 versions
TAVSE Estrabauda, P Marcellina - Front Gastrointest Res, 2010 - mizpahpublishing.org Abstract Hepatitis C is among the leading causes of chronic liver disease worldwide, with a
prevalence of approximately170 million cases. The severity of disease varies from
asymptomaticchronic infection to ... Related articles - View as HTML
AI Med - Ann Intern Med, 2009 - Am Coll Physicians We thank Professor Poynard for his interest in our article and for pointing out some differences
between the non-comparative EPIC3 trial(1) and the randomized international REPEAT trial.(2) We
agree that differences in the ...
M Leise, WR Kim - Hepatology (Baltimore, Md.), 2009 - ncbi.nlm.nih.gov 1: Hepatology. 2009 Oct;50(4):1307-9. Comment on: Ann Intern Med. 2009 Apr 21;150(8):528-40.
Hepatitis C nonresponders: re-treat or retreat? Leise M, Kim WR. Division of Gastroenterology
and Hepatology, Mayo Clinic, College of Medicine, Rochester, MN, USA. ... Related articles - All 2 versions
DT Dieterich, M Rizzetto, MP Manns - Journal of Viral Hepatitis, 2009 - interscience.wiley.com Summary. Development of therapeutic strategies for patients with chronic hepatitis C who experience
virological breakthrough, relapse or nonresponse lag behind those for treatment-naïve patients. The
probability of a previously treated ...
T Asselah, V Soumelis, E Estrabaud, P Marcellin - 2009 - content.karger.com Abstract: Hepatitis C is among the leading causes of chronic liver disease worldwide, with a
prevalence of approximately 170 million cases. The severity of disease varies from
asymptomaticchronic infection to ...